Practice question

Answer the question and get instant feedback.

ModerateCardiologyHeart Failure (HFrEF)us-abfmus-abimus-usmle-step-2us-usmle-step-3

A 59-year-old with chronic HFrEF (LVEF 30%), NYHA II, is on sacubitril/valsartan, carvedilol, and spironolactone. eGFR 45 mL/min/1.73 m², potassium 4.5 mEq/L. Which medication addition provides further mortality and HF hospitalization benefit?

Educational content. Not a substitute for clinical judgement or local policy.